Friedrich–Alexander University Erlangen–Nurnberg

Medications

New approaches in the fight against drug resistance in malaria

Malaria is one of the most widespread and deadly infectious diseases worldwide. New compounds are continuously required due to the risk of malaria parasites becoming resistant to the medicines currently used. A team of researchers ...

Medications

Printing pills with a 3D printer

Almost a third of the population in Germany needs to take medication on a daily basis. One in four of these people regularly takes three or more different types of medication at the same time. Various pills pile up in these ...

Immunology

How vitamin D3 helps allergic asthma

A vitamin D3 deficiency can lead to severe symptoms, for example in people suffering from allergic asthma. This has already been shown in several studies. However, we still do not fully understand how exactly this vitamin ...

Psychology & Psychiatry

Exploring the positive aspects of caring for relatives at home

Fatigue, stress, scarcely any free time or feeling unappreciated: Those caring at home for relatives suffering from conditions such as dementia often feel overwhelmed or under great mental strain. For the first time in Germany, ...

Diseases, Conditions, Syndromes

How macrophages use metabolic product to combat Q fever pathogen

Q fever can lead to pneumonia, and can attack several organs at once if it becomes chronic. Treatment with antibiotics is lengthy and only has limited success. But which factors in our immune system protect against chronic ...

Diseases, Conditions, Syndromes

COVID: On the lookout for new antibodies

A team of researchers at FAU and Universitätsklinikum Erlangen has gained new insights into the maturation of SARS-CoV-specific antibodies after multiple vaccinations with the Comirnaty mRNA vaccine. They have now published ...

Medical research

Potential new treatments for Huntington's disease

Huntington's disease is caused by repeated toxic changes in the protein huntingtin. An interdisciplinary team from the Department of Molecular Neurology and the Department of Stem Cell Biology at Universitätsklinikum Erlangen ...

page 2 from 3